Global Continuous Glucose Monitoring Devices Market 2025

Posted by Robson Tolson on December 11th, 2017

The latest market report published by Credence Research, Inc. “Continuous Glucose Monitoring Devices Market: Growth, Future Prospects, and Competitive Analysis, 2017 -2025” the continuous glucose monitoring devices market was valued at US$ 1.3 bn in 2016, and is expected to show a lucrative growth in the forecast period, 2017-2025.

Browse the full report Continuous Glucose Monitoring Devices Market: Growth, Future Prospects, and Competitive Analysis, 2017 -2025 report at

Market Insights:

Diabetes is a condition of major global concern. As per the World Health Organization, 422 million people were affected with diabetes in the year 2014. In 2015, 1.6 million deaths were caused by diabetes. This prevalence is expected to increase further in the forecast period. Effective management and continuous monitoring of glucose levels thus becomes essential in order to provide timely patient-centric care and cope with the disease.

Continuous glucose monitoring (CGM) devices are latest advancement in diabetes monitoring devices. CGM devices consist of a sensor placed on the patient’s skin. The sensor measures glucose levels periodically in the interstitial fluid and provides a trend data which is captured via a transmitter to the receiver. This enables determining any fluctuation in the glucose levels thus rendering the required patient care unlike the traditional self-monitoring blood glucose (SMBG) devices wherein interim glucose fluctuations are difficult to monitor.

These newer devices are projected to show positive market growth in the forecast period 2017-2025. The catalysts that drive the CGM devices market are increasing diabetic population, rise in technological development such as addition of smart connectivity options enabling remote assistance from physicians, rising demand for patient specific treatment approaches, increased awareness of CGM devices amongst payers thus providing structured reimbursement policies and developing healthcare infrastructure.

North America accounts for major share in the continuous glucose monitoring devices market due to existence of developed healthcare infrastructure, favorable reimbursement policies, drive towards attaining a patient-centric healthcare approach and technological advancements in healthcare monitoring.  The rising prevalence of diabetes in emerging economies such as India, China, Latin America and Middle East & Africa due to growing life expectancy will also fuel the CGM devices market. However, high pricing of these devices, uneasiness observed in patients using CGM devices, and insufficient existence of healthcare IT products and services may lead to sluggish growth of CGM devices market in the aforementioned geographies.

Market Competition Assessment:

The CGM devices market comprises of an extensive competitive pool. This market provides extensive opportunities for emerging key players with more advanced glucose monitoring devices. The emerging key players would face regulatory challenges while entering the CGM devices market owing to stringent government regulations and approval policies.

The current market leaders are DexCom with its CGM product G5 Mobile and Abbott Laboratories with its product FreeStyle Libre. The other existing and emerging key players in this market are Echo Therapeutics, Inc., Johnson & Johnson, GlySens Incorporated, Medtronic plc, Inc., F. Hoffmann-La Roche Ltd., Senseonics Holdings AgaMatrix, Inc., Glucovation, GlySure, Arkray USA, Inc., Pinnacle Technology, Tandem Diabetes Care, OrSense

Key Market Movements:

  • An increasing prevalence of diabetes and rise in demand for patient centric treatment has propelled the CGM devices market
  • The expertise for handling CGM devices, higher pricing and stringent regulatory approval process could hinder the growth of this market


About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

What we do

We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.

No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.

Media Contact

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US

Ph: 1-800-361-8290


Like it? Share it!

Robson Tolson

About the Author

Robson Tolson
Joined: February 21st, 2017
Articles Posted: 620

More by this author